BridgeMD
New treatment option for AD
Official title A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov ID: NCT07693738
What this study is testing
What is SSGJ-716?
SSGJ-716 is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for ad.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this Phase 1 study is to evaluate the safety and tolerability of a new investigational drug called SSGJ-716 in healthy adults and in participants with moderate-to-severe atopic dermatitis (AD). The study has two parts.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45. Healthy volunteers may be eligible.
You may be able to join if
- Able to understand protocol requirements and sign a written ICF.
- Male or female people aged 18-45 years when signing the ICF.
- Male people with body weight ≥ 50 kg, and female people with body weight ≥ 45 kg. people with BMI between 18 and 28 kg/m2.
- people whose test results are normal, or abnormal without clinical significance as determined by the investigator.
- Female people with childbearing potential and male people (and their female partners) must agree to take highly effective contraceptive measures.
You likely can't join if
- History of severe allergy, or with a history of allergy to the study treatment or related excipients.
- With any clinically significant diseases prior to the screening visit. people with positive test results for hepatitis B surface antigen (HBsAg)...
- History of of significant alcohol abuse.
- History of significant drug abuse.
- people who have positive result for urine nicotine test at screening. Pregnant, or nursing females.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 45 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.